Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02611323
Brief Title: A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

First Submitted : November 19, 2015
First Submitted that Met QC Criteria : November 19, 2015
First Posted : November 20, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : October 11, 2019
Last Update Posted : October 14, 2019